We are live on ! Find out more
TRIB

Trinity Biotech
TRIB

70 hedge funds and large institutions have $251M invested in Trinity Biotech in 2013 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

50% more call options, than puts

Call options by funds: $614K | Put options by funds: $409K

32% more capital invested

Capital invested by funds: $191M → $251M (+$60.4M)

9% more funds holding

Funds holding: 64 → 70 (+6)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

4% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 24

Holders
70
Holders Change
+6
Holders Change %
+9.38%
% of All Funds
2.27%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
15
Increased
23
Reduced
24
Closed
8
Calls
$614K
Puts
$409K
Net Calls
+$205K
Net Calls Change
+$373K

Top Buyers

Rank Fund Capital Flow
1
CCMLC
Cardinal Capital Management LLC (Connecticut)
Connecticut
+$4.26M
2
TAM
THB Asset Management
Connecticut
+$3.4M
3
William Blair & Company
William Blair & Company
Illinois
+$2.82M
4
Renaissance Technologies
Renaissance Technologies
New York
+$2.01M
5
WA
Whitebox Advisors
Minnesota
+$1.95M

Top Sellers

Rank Fund Capital Flow
1
HA
Heartland Advisors
Wisconsin
-$6.23M
2
Boston Partners
Boston Partners
Massachusetts
-$2.17M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.01M
4
UCFA
United Capital Financial Advisors
Texas
-$1.88M
5
CCM
Corsair Capital Management
New York
-$1.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$44.2M -$2.01M -20,584 -5%
HA
2
Heartland Advisors
Wisconsin
$27.2M -$6.23M -63,867 -20%
William Blair & Company
3
William Blair & Company
Illinois
$18.9M +$2.82M +28,912 +20%
AAM
4
ACK Asset Management
Connecticut
$14.6M +$292K +3,000 +2%
Renaissance Technologies
5
Renaissance Technologies
New York
$11.1M +$2.01M +20,630 +25%
CIP
6
Chartwell Investment Partners
Pennsylvania
$10.9M -$534K -5,480 -5%
PWAM
7
Park West Asset Management
California
$10.5M +$681K +6,988 +8%
KCM
8
Kennedy Capital Management
Missouri
$9.36M +$483K +4,950 +6%
LSC
9
Lyon Street Capital
California
$8.87M +$755K +7,745 +10%
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$8.44M -$1.35M -13,870 -15%
RA
11
Royce & Associates
New York
$7.44M +$121K +1,240 +2%
GCM
12
Goldman Capital Management
New York
$6.79M -$604K -6,200 -9%
WA
13
Whitebox Advisors
Minnesota
$6.29M +$1.95M +20,000 +53%
Allianz Asset Management
14
Allianz Asset Management
Germany
$5.6M +$966K +9,906 +24%
CCMLC
15
Cardinal Capital Management LLC (Connecticut)
Connecticut
$5.11M +$4.26M +43,662 +1,339%
GPP
16
Great Point Partners
Connecticut
$4.11M +$3.69M +37,814 New
TAM
17
THB Asset Management
Connecticut
$3.79M +$3.4M +34,830 New
ARM
18
Adirondack Research & Management
New York
$3.51M – – –
SKK
19
Shepherd Kaplan Krochuk
Massachusetts
$3.39M -$196K -2,007 -6%
DGHMC
20
Dalton, Greiner, Hartman, Maher & Co
New York
$2.93M -$203K -2,086 -7%
OSAM
21
O'Shaughnessy Asset Management
Connecticut
$2.79M -$599K -6,148 -19%
TA
22
Teton Advisors
New York
$2.72M – – –
GA
23
Geneva Advisors
Illinois
$2.68M +$387K +3,968 +19%
CCI
24
Columbus Circle Investors
$1.77M +$1.59M +16,278 New
RFC
25
Russell Frank Company
Washington
$1.74M +$472K +4,842 +43%
1
2 3 4

TRIB Hedge Fund Activity: Q3 2013 in Review

70 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q3 2013, worth a combined $251M — up 32% from $191M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new TRIB positions and 8 closed out — a net gain of 7 holders — while 23 added to existing stakes and 24 trimmed.

The largest buyer was Cardinal Capital Management LLC (Connecticut), adding an estimated $4.26M. The largest seller was Heartland Advisors, cutting an estimated $6.23M.

  • 70 institutional investors held Trinity Biotech (TRIB) as of Q3 2013, up from 64 in Q2 2013.
  • Funds reported $251M of Trinity Biotech stock for Q3 2013, up 32% quarter-over-quarter.
  • 15 funds opened new Trinity Biotech positions in Q3 2013 and 8 closed out, a net change of +7 holders.
  • The largest Trinity Biotech buyer in Q3 2013 was Cardinal Capital Management LLC (Connecticut), an estimated $4.26M added.
  • The largest Trinity Biotech seller in Q3 2013 was Heartland Advisors, an estimated $6.23M sold.

Based on aggregated 13F filings for Q3 2013.